Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11086714rdf:typepubmed:Citationlld:pubmed
pubmed-article:11086714lifeskim:mentionsumls-concept:C0006784lld:lifeskim
pubmed-article:11086714lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:11086714lifeskim:mentionsumls-concept:C0733755lld:lifeskim
pubmed-article:11086714lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:11086714lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:11086714lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:11086714lifeskim:mentionsumls-concept:C0376211lld:lifeskim
pubmed-article:11086714lifeskim:mentionsumls-concept:C0668269lld:lifeskim
pubmed-article:11086714pubmed:issue22lld:pubmed
pubmed-article:11086714pubmed:dateCreated2001-2-12lld:pubmed
pubmed-article:11086714pubmed:abstractTextA series of novel ketoamides incorporating all four 2,3-methanoleucine stereoisomers at the P2 position was synthesized. The compounds displayed a wide variation in Ki values for inhibition of calpain I depending on the configuration of the P2 methanoleucine residue. However, similar variation in cathepsin B inhibition was not observed suggesting that the S2 pocket of calpain I is more stereosensitive than that of cathepsin B.lld:pubmed
pubmed-article:11086714pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11086714pubmed:languageenglld:pubmed
pubmed-article:11086714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11086714pubmed:citationSubsetIMlld:pubmed
pubmed-article:11086714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11086714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11086714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11086714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11086714pubmed:statusMEDLINElld:pubmed
pubmed-article:11086714pubmed:monthNovlld:pubmed
pubmed-article:11086714pubmed:issn0960-894Xlld:pubmed
pubmed-article:11086714pubmed:authorpubmed-author:MillerD DDDlld:pubmed
pubmed-article:11086714pubmed:authorpubmed-author:ZhengXXlld:pubmed
pubmed-article:11086714pubmed:authorpubmed-author:DonkorI OIOlld:pubmed
pubmed-article:11086714pubmed:issnTypePrintlld:pubmed
pubmed-article:11086714pubmed:day20lld:pubmed
pubmed-article:11086714pubmed:volume10lld:pubmed
pubmed-article:11086714pubmed:ownerNLMlld:pubmed
pubmed-article:11086714pubmed:authorsCompleteYlld:pubmed
pubmed-article:11086714pubmed:pagination2497-500lld:pubmed
pubmed-article:11086714pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11086714pubmed:meshHeadingpubmed-meshheading:11086714...lld:pubmed
pubmed-article:11086714pubmed:meshHeadingpubmed-meshheading:11086714...lld:pubmed
pubmed-article:11086714pubmed:meshHeadingpubmed-meshheading:11086714...lld:pubmed
pubmed-article:11086714pubmed:meshHeadingpubmed-meshheading:11086714...lld:pubmed
pubmed-article:11086714pubmed:year2000lld:pubmed
pubmed-article:11086714pubmed:articleTitleSynthesis and calpain inhibitory activity of alpha-ketoamides with 2,3-methanoleucine stereoisomers at the P2 position.lld:pubmed
pubmed-article:11086714pubmed:affiliationDepartment of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis 38163, USA. idonkor@utmem.edulld:pubmed
pubmed-article:11086714pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11086714pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11086714pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:11086714lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11086714lld:pubmed